ATE164068T1 - Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung - Google Patents

Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung

Info

Publication number
ATE164068T1
ATE164068T1 AT93310464T AT93310464T ATE164068T1 AT E164068 T1 ATE164068 T1 AT E164068T1 AT 93310464 T AT93310464 T AT 93310464T AT 93310464 T AT93310464 T AT 93310464T AT E164068 T1 ATE164068 T1 AT E164068T1
Authority
AT
Austria
Prior art keywords
ophthalmic
antiallergic composition
nasal use
antiallergic
composition
Prior art date
Application number
AT93310464T
Other languages
English (en)
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE164068T1 publication Critical patent/ATE164068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93310464T 1992-12-25 1993-12-23 Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung ATE164068T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (1)

Publication Number Publication Date
ATE164068T1 true ATE164068T1 (de) 1998-04-15

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93310464T ATE164068T1 (de) 1992-12-25 1993-12-23 Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung

Country Status (23)

Country Link
US (1) US5419898A (de)
EP (1) EP0605203B1 (de)
JP (1) JP3683595B2 (de)
KR (1) KR100276743B1 (de)
CN (1) CN1050514C (de)
AT (1) ATE164068T1 (de)
AU (1) AU666413B2 (de)
BG (1) BG61101B1 (de)
CA (1) CA2112014C (de)
CZ (1) CZ283029B6 (de)
DE (1) DE69317537T2 (de)
DK (1) DK0605203T3 (de)
ES (1) ES2115733T3 (de)
FI (1) FI111805B (de)
HU (2) HU218672B (de)
LT (1) LT3344B (de)
LV (1) LV10688B (de)
NO (2) NO934630D0 (de)
NZ (1) NZ250519A (de)
PL (1) PL173347B1 (de)
RU (1) RU2130774C1 (de)
SK (1) SK279503B6 (de)
TW (1) TW401300B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (de) * 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2001501212A (ja) * 1996-09-27 2001-01-30 ナステック ファーマシューティカル カンパニー インク 睡眠促進用鼻腔内調製物及び同物を用いる方法
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (de) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphische Formen der 2-2-4-Bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxyessigsäure Dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
EP1109581A1 (de) 1998-09-02 2001-06-27 Allergan Sales, Inc. Geschützte cyclodextrin-enthaltende zusammensetzungen
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
US20050038039A1 (en) * 2002-01-15 2005-02-17 Domenico Fanara Formulations
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
EP1750677B1 (de) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US20080075784A1 (en) * 2004-07-22 2008-03-27 Pfizer Inc. Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced Form
JP5042215B2 (ja) 2005-05-26 2012-10-03 ニューロン システムズ， インコーポレイテッド 網膜疾患を処置するための組成物および方法
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
RU2008140298A (ru) * 2006-03-13 2010-04-20 Р-Тек Уено, Лтд. (Jp) Водная композиция
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
EP2408453B1 (de) 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmische formulierungen aus cetirizin und verfahren zu ihrer verwendung
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
JP2013501735A (ja) * 2009-08-12 2013-01-17 ルナン ベター ファーマシューティカル カンパニー リミテッド セチリジン塩酸塩の薬剤溶液
WO2011057192A2 (en) 2009-11-06 2011-05-12 Yale University Amphiphilic compositions and methods for preparing and using same
SG10201506273PA (en) 2011-11-29 2015-09-29 Jurox Pty Ltd Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
KR102243169B1 (ko) 2013-01-23 2021-04-22 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
EP3337486B1 (de) 2015-08-21 2024-04-03 Aldeyra Therapeutics, Inc. Deuterierte verbindungen und verwendungen davon
CA3016759A1 (en) 2016-02-28 2017-08-31 Aldeyra Therapeutics, Inc. Treatment of allergic eye conditions with cyclodextrins
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
US11241426B2 (en) * 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
WO2018170476A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
EP3694500A4 (de) 2017-10-10 2021-06-30 Aldeyra Therapeutics, Inc. Behandlung von entzündungserkrankungen
AU2019209214B2 (en) 2018-01-18 2023-11-23 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
JP2021533154A (ja) 2018-08-06 2021-12-02 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
CN115869258A (zh) 2018-09-25 2023-03-31 奥尔德拉医疗公司 用于治疗干眼病的调配物
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
LV10688B (en) 1995-10-20
NZ250519A (en) 1995-03-28
CA2112014A1 (en) 1994-06-26
FI935851A0 (fi) 1993-12-23
FI935851A (fi) 1994-06-26
JPH06239748A (ja) 1994-08-30
AU5259793A (en) 1994-07-07
HUT69385A (en) 1995-09-28
SK147493A3 (en) 1994-07-06
CZ283029B6 (cs) 1997-12-17
EP0605203A2 (de) 1994-07-06
LT3344B (en) 1995-07-25
CA2112014C (en) 2004-11-02
KR940013511A (ko) 1994-07-15
BG98327A (bg) 1994-08-30
NO304176B1 (no) 1998-11-09
KR100276743B1 (ko) 2001-01-15
US5419898A (en) 1995-05-30
NO934630D0 (no) 1993-12-15
RU2130774C1 (ru) 1999-05-27
CZ283693A3 (en) 1994-07-13
PL301588A1 (en) 1994-06-27
FI111805B (fi) 2003-09-30
NO934630L (no) 1994-06-27
JP3683595B2 (ja) 2005-08-17
CN1050514C (zh) 2000-03-22
BG61101B1 (bg) 1996-11-29
CN1094614A (zh) 1994-11-09
LV10688A (lv) 1995-06-20
DK0605203T3 (da) 1998-12-07
AU666413B2 (en) 1996-02-08
DE69317537T2 (de) 1998-07-09
EP0605203A3 (de) 1994-11-02
HU9303746D0 (en) 1994-04-28
LTIP1669A (en) 1994-10-25
EP0605203B1 (de) 1998-03-18
TW401300B (en) 2000-08-11
ES2115733T3 (es) 1998-07-01
PL173347B1 (pl) 1998-02-27
HU218672B (hu) 2000-10-28
DE69317537D1 (de) 1998-04-23
HU211972A9 (en) 1996-01-29
SK279503B6 (sk) 1998-12-02

Similar Documents

Publication Publication Date Title
ATE164068T1 (de) Antiallergische zusammensetzung zur ophthalmischen oder nasalen anwendung
RU93056633A (ru) Антиаллергическая композиция для лечения глаз или носа
DE69025107D1 (de) Antimikrobizides Gemisch
ATE163259T1 (de) Mittel zur regulierung vom hautfettigkeitsgrad
ES2071227T3 (es) Composicion para gotas para los ojos.
AU3354895A (en) Novel medicinal use of 5ht3 antagonist
DE69310303D1 (de) Gerät zur topografischen Bestimmung anatomischer Oberflächen, insbesondere der Kornea
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
ATE179073T1 (de) Asthma heilmittel
EP0398084A3 (de) Nitro-substituierte heterozyklische Verbindungen
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
EP0272704A3 (de) Verwendung von Pyrazolderivaten zur Behandlung von Immunkrankheiten und Nephropathie
IT1197081B (it) Composizione sterilizzante ad attivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
EP1130018A4 (de) Heilmittel gegen drogenabhängigkeit
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee